Here is the summary:

DRREDDY's weekly performance was disappointing, with a return of -2.34% and a Sharpe Ratio of -0.61, indicating poor risk-adjusted returns. The stock's volatility was high at 20.37%, making it a risky investment this week. Compared to its peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but was outperformed by HINDUNILVR. Overall, the stock's high volatility and negative returns make it a cautionary investment.

[Volatility: 20.37%]